logo-loader

Naked Biome aiming to treat acne with its microbiome-based skin therapeutics

Published: 20:38 13 Jan 2020 EST

 

Naked Biome CEO Emma Taylor joined Proactive at the Biotech Showcase 2020 in San Francisco. The San Francisco-based microbiome-based skin therapeutics company is building a drug discovery genomics platform to treat skin diseases.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

52 minutes ago